Trademark Details For GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT (Serial Number 87660522)

  •  Home
  •  Print
GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT
0
0
0
0
word.basic_information
Serial Number  United States - USPTO 87660522
Registration Number 6396881
Mark
GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT
Filing Date Oct-26-2017
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0
Action Tags
  


  • GENESIS DRUG, DISCOVERY & DEVELOPMENT, LLC

  • Mark Literal Elements:
  • Description Of Mark:
  • Color(s) Claimed:
  • Disclaimer:

042Computer, scientific and legal

U.S Class(es): 100, 101

Class Status: Active

First Use: 2017

First Use in Commerce: 2017


01.09.05
10.09.01
26.11.26
26.19.01



Correspondences

NameChristina E. Brule
AddressHeslin Rothenberg Farley & Mesiti P.C. 5 Columbia Circle Albany,NY 12203

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-30-2017NEW APPLICATION ENTERED   NWAPI
Nov-04-2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Nov-07-2017NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSME
Feb-06-2018ASSIGNED TO EXAMINER   DOCKD
Feb-21-2018
NON-FINAL ACTION WRITTEN
  
CNRTR
Feb-21-2018NON-FINAL ACTION E-MAILED   GNRTF
Feb-21-2018
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Aug-17-2018TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Aug-17-2018CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Aug-18-2018TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Sep-06-2018SUSPENSION LETTER WRITTEN   CNSLR
Sep-06-2018LETTER OF SUSPENSION E-MAILED   GNSLS
Sep-06-2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED   GNS3O
Mar-26-2019ASSIGNED TO LIE   ALIEA
Mar-28-2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED   RCSCS
Oct-10-2019SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION   RCCKS
Nov-01-2019FINAL REFUSAL WRITTEN   CNFRR
Nov-01-2019
FINAL REFUSAL E-MAILED
  
GNFRO
Nov-01-2019
NOTIFICATION OF FINAL REFUSAL EMAILED
  
GNFNO
Jan-14-2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Jan-14-2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Feb-03-2020TEAS REQUEST FOR RECONSIDERATION RECEIVED   ERFRI
Feb-03-2020CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Feb-04-2020TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Feb-10-2020APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Feb-26-2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Mar-17-2020PUBLISHED FOR OPPOSITION   PUBOA
Mar-17-2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
May-12-2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Oct-16-2020TEAS STATEMENT OF USE RECEIVED   EISUI
Oct-31-2020CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Oct-16-2020USE AMENDMENT FILED   IUAFS
Oct-31-2020STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Nov-02-2020SU - NON-FINAL ACTION - WRITTEN   CNRTW
Nov-02-2020
NON-FINAL ACTION E-MAILED
  
GNRTO
Nov-02-2020
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Apr-21-2021TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Apr-28-2021CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Apr-28-2021TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Apr-30-2021ASSIGNED TO EXAMINER   DOCKD
May-17-2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
May-18-2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Jun-22-2021REGISTERED-PRINCIPAL REGISTER   R.PRA
Sep-15-2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Sep-15-2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Sep-15-2023TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Sep-15-2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS   EWAFI